Skip to main content

Advertisement

Log in

The prognostic value of hTERT expression levels in advanced-stage colorectal cancer patients: a comparison between tissue and serum expression

  • Research Articles
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Aim

Telomeres are regions of highly repetitive, non-coding DNA located at the termini of chromosomes whose principal function is to maintain the structural stability of these ends. In 90% of human tumours, telomere length is maintained by the expression and activation of telomerase reverse transcriptase. Various studies have demonstrated an increase in telomerase activity in tumour tissue, which suggests its possible prognostic value. The main objective of our study was to study the prognostic value of the expression level of telomerase catalytic component (hTERT) in patients with colorectal cancer (CRC).

Methods

We analysed the prognostic value of the ratio of telomerase expression in tumour tissue to telomerase expression in the adjacent healthy mucosa and the prognostic value of the expression level of hTERT in the serum of patients diagnosed with CRC. As secondary objectives of the study, we (1) analysed the correlation between telomerase expression in the serum and that in the tumour tissue and (2) analysed the relationship between telomerase expression and different clinical parameters.

Results

Peripheral blood and tissue samples taken from 48 patients with CRC were analysed. No significant differences were observed in disease-free survival (DFS) or overall survival time (OST) between the groups of patients categorised based on the ratio of telomerase expression between tumour tissue and healthy tissue. The correlation index (Pearson’s coefficient) between telomerase levels in the serum and those in tissue was 0.32. Our study of the relationship between telomerase levels in the serum and different clinical variables, such as tumour size, ganglion affectation, preoperative carcinoembryonic antigen levels and stage, revealed a higher telomerase expression level in patients with stage IV CRC. There was no significant association between telomerase expression in tumour tissue and the clinical parameters analysed.

Conclusions

The results obtained in our study do not allow us to propose that the level of telomerase expression be used as a prognostic factor in colorectal cancer. Thus, we cannot consider telomerase expression in the serum as a surrogate marker of its expression in tumour tissue.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Blasco MA (2005) Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet 6:611–622

    Article  PubMed  CAS  Google Scholar 

  2. Hahn WC, Weinberg RA (2002) Rules for making humor tumor cells. N Engl J Med 347:1593–1603

    Article  PubMed  CAS  Google Scholar 

  3. Kim NW, Piatyszek MA, Prowse KR et al (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011–2015

    Article  PubMed  CAS  Google Scholar 

  4. Hiyama E, Gollahan L, Kataoka T et al (1995) Telomerase activity in gastric cancer. Cancer Res 55:3258–3262

    PubMed  CAS  Google Scholar 

  5. Tahara H, Kuniyasu H, Yokozaki H et al (1995) Telomerase activity in preneoplasic and neoplastic gastric and colorectal lesions. Clin Cancer Res 1:1245–1251

    PubMed  CAS  Google Scholar 

  6. Hiyama E, Kodama T, Sinbara K et al (1997) Telomerase activity is detected in pancreatic cancer but not in benign tumors. Cancer Res 57: 326–331

    PubMed  CAS  Google Scholar 

  7. Engelhardt M, Drullinsky P, Guillem J et al (1997) Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin Cancer Res 3:1931–1941

    PubMed  CAS  Google Scholar 

  8. Shay JW, Werbin H, Wright WE (1997) Telomerase assay in the diagnosis and prognosis of cancer. CIBA Found Symp 211:148–155

    PubMed  CAS  Google Scholar 

  9. Saleh S, Lam AK, Ho YH (2008) Real-time PCR quantification of human telomerase reverse transcriptase (hTERT) in colorectal cancer. Pathology 40:25–30

    Article  PubMed  CAS  Google Scholar 

  10. Kanamaru T, Tanaka K, Kotani J et al (2002) Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer. Int J Mol Med 10:205–210

    PubMed  CAS  Google Scholar 

  11. Gonzalo V, Petit A, Castellví-Bel S et al (2010) Telomerase mRNA expression and immunohis-tochemical detection as a biomarker of malignant transformation in patients with inflammatory bowel disease. Gastroenterol Hepatol 33:288–296

    Article  PubMed  Google Scholar 

  12. Hiyama K, Hirai Y, Kyoizumi et al (1995) Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 155: 3711–3715

    PubMed  CAS  Google Scholar 

  13. Taylor RS, Ramirez RD, Ogoshi M et al (1996) Detection of telomerase activity in malignant and nonmalignant skin condition. J Invest Dermatol 106:756–765

    Article  Google Scholar 

  14. Hiyama E, Hiyama K, Tatsumoto N et al (1996) Telomerase activity in human intestine. Int J Oncol 9:453–458

    PubMed  CAS  Google Scholar 

  15. Tatsumoto N, Hiyama E, Murakami Y et al (2000) High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer. Clin Cancer Res 6:2696–2701

    PubMed  CAS  Google Scholar 

  16. Gertler R, Rosenberg R, Stricker D et al (2002) Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma. Cancer 95:2103–2111

    Article  PubMed  CAS  Google Scholar 

  17. Gertler R, Rosenberg R, Stricker D et al (2004) Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis on colorectal carcinoma. J Clin Oncol 22:1807–1814

    Article  PubMed  CAS  Google Scholar 

  18. Boldrini L, Faviana P, Gisfredi S et al (2004) Regulation of telomerase and its hTERT messenger in colorectal cancer. Oncol Rep 11:395–400

    PubMed  CAS  Google Scholar 

  19. Garcia-Aranda C, de Juan C, Diaz-Lopez A et al (2006) Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma. Cancer 106: 541–551

    Article  PubMed  CAS  Google Scholar 

  20. Hess JL, Highsmith E (2002) Telomerase detection in body fluids. Clin Chem 48:18–24

    PubMed  CAS  Google Scholar 

  21. Cheng X, Bonnefoi H, Pelte M-F et al (2000) Telomerase RNA as a detection marker in the serum of breast cancer patients. Clin Cancer Res 6:3823–3826

    Google Scholar 

  22. Ohnishi T, Watanabe T, Nozawa H et al (2008) Telomerase activity of blood samples and recurrence of colorectal cancer. Hepatogastroenterology 55:1513–1518

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carlos Camps.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Safont, M.J., Gil, M., Sirera, R. et al. The prognostic value of hTERT expression levels in advanced-stage colorectal cancer patients: a comparison between tissue and serum expression. Clin Transl Oncol 13, 396–400 (2011). https://doi.org/10.1007/s12094-011-0673-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-011-0673-2

Keywords

Navigation